6d agoThe Motley FoolBULLISH 68Earnings
TMO Q2 2026 Earnings Call Transcript
Organic revenue beat guidance at 5% as pharma and biotech activity strengthened.
Archived explainer. For the current picture see today's TMO page.
Why Is THERMO FISHER SCIENT (TMO) Stock Up Today?
By the Top Tier Newswire AI Desk · July 24, 2026 at 7:09 AM ET · reviewed against 14 wire stories
THERMO FISHER SCIENT (TMO) is up +8.71% in the latest session. Our newswire has captured 14 stories on TMO across 10 sources in the last 36 hours, with AI sentiment reading bullish (avg 64/100).
Thermo Fisher Scientific (TMO) surged 8.71% to $572.32 in a session marked by strong earnings and revised guidance. The stock climbed following the release of better-than-expected second-quarter results and an upward revision of full-year 2026 guidance. Management highlighted stronger customer activity, particularly in the pharmaceutical and biotechnology sectors, as a key driver of performance.
What Happened
Thermo Fisher Scientific reported Q2 2026 results that exceeded expectations, with organic revenue growth of 5%. The company raised its full-year 2026 revenue guidance to a range of $47.4 billion to $48.1 billion and adjusted EPS guidance to $24.93 to $25.33. These updates reflect improved end-market activity and margin expansion. The microbiology division's divestiture also contributed to a cleaner financial picture, while the company continued its buyback program and launched new AI-powered products. The improved outlook and strong performance led to a sharp rise in the stock price.
What The Data Shows
TMO's fundamentals reflect a strong market position with a market cap of $195.6 billion, a P/E ratio of 31.5, and trailing 12-month revenue growth of 5.4%. The company's net margin stands at 15.2%, and its beta of 0.87 suggests lower volatility than the broader market. The stock opened at $566.61, a 1.0% gap down from the prior close, but the session saw no intraday movement beyond the opening price. Volume has been negligible so far, at 0.0 million shares traded. The stock is currently within its 52-week range of $435.27 to $643.99, having printed one fresh 52-week high on July 24.
What To Watch
The company is scheduled to provide updated 2025 guidance in its Q3 2025 earnings report, which will be a key event for investors. Coverage breadth is also worth monitoring, as 14 stories from 10 sources have been published in the last 36 hours.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Not financial advice.
TMO by the numbers
Last: $572.32Session: +8.71%Coverage: 14 stories / 10 sourcesAI sentiment: 64/100 (bullish)Mkt cap: $195.6BP/E: 31.552w: $435.27 to $643.99
The headlines behind the move
6d agoSeeking AlphaBULLISH 71Earnings
Thermo Fisher signals 2026 revenue of $47.4B-$48.1B and adjusted EPS of $24.93-$25.33 as customer activity strengthens
Thermo Fisher (TMO) Q2 2026 earnings call recap: revenue/EPS beat, raised 2026 guidance, microbiology divestiture impact, and buybacks—read now.
6d agoSeeking AlphaNEUTRAL 50Earnings
Thermo Fisher Scientific Inc. (TMO) Q2 2026 Earnings Call Transcript
Thermo Fisher Scientific Inc. (TMO) Q2 2026 Earnings Call July 23, 2026 8:30 AM EDTCompany ParticipantsRafael Tejada - Vice President of Investor...
6d agoMarketChameleonBULLISH 73Earnings
Thermo Fisher's Strong Q2: Revenue Growth and Margin Expansion Signal Robust Outlook July 23, 2026
Thermo Fisher Scientific reported a robust second quarter, with double-digit revenue growth, expanding margins, product innovation, and strategic investments that signal resilience and future momentum. Key financials and business highlights offer actionable insights for investors and the scientific community.
6d agoYahoo FinanceBULLISH 63General
The 'Standout Performance' That Could Save Thermo Fisher, Danaher And Others
6d agoInvestorsHubBULLISH 68Earnings
Thermo Fisher beats second-quarter expectations as customer demand strengthens (NYSE:TMO)
Thermo Fisher beat second-quarter earnings and revenue expectations as customer demand strengthened, while the company expanded margins, launched new AI-powered products and continued investing in growth.
6d agoSeeking AlphaBULLISH 68Earnings
Thermo Fisher rebounds after Q2 beat
Thermo Fisher Scientific (TMO) stock jumps as the company reports better than expected financials for Q2 2026. Read more here.
6d agoMarketChameleonBULLISH 73Earnings
Thermo Fisher’s Strong Q2: Robust Growth, New Innovation, and Higher Margins Mark a Standout Quarter July 23, 2026
Thermo Fisher Scientific’s second quarter of 2026 showcased double-digit revenue growth, notable advances in operating margins, and new product launches, positioning TMO for continued market leadership.
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →
More on TMO: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier TMO move explainers: 2026-07-24 · 2026-07-23